✦ LIBER ✦

The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study

✍ Scribed by K. M. Fleming; G. P. Aithal; T. R. Card; J. West

Book ID: 108606095
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 260 KB
Volume: 32
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2010.04473.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rate of clinical progression in Parkinso

Rate of clinical progression in Parkinson's disease. A prospective study

✍ Anette Schrag; Richard Dodel; Annika Spottke; Bernhard Bornschein; Uwe Siebert; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Abstract Few prospective data on the clinical progression of Parkinson's disease (PD) in patient groups outside treatment trials in selected patients are available, and controversy exists on the rate of clinical disease progression with advancing disease. In this study, we investigated the rate

Smoking is associated with progressive d

Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis

✍ Fotini Pittas; Anne-Louise Ponsonby; Ingrid A. F. van der Mei; Bruce V. Taylor; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 203 KB

Portosystemic shunts in a large cohort o

Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance

✍ Enrico Maria Zardi; Valentina Uwechie; Domenico Caccavo; Nelly Maria Pellegrino; 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 295 KB

Social and clinical determinants of qual

Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study

✍ Yaroslav Winter; Sonja von Campenhausen; Julia Gasser; Klaus Seppi; Jens-P. Rees 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 269 KB

Rate of progression in Parkinson's disea

Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study

✍ Elina Nurmi; Hanna M. Ruottinen; Jörgen Bergman; Merja Haaparanta; Olof Solin; P 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## Abstract The aim of this study was to investigate the rate of progression in Parkinson's disease (PD) with 6‐[^18^F]fluoro‐L‐dopa (FDOPA) positron emission tomography (PET). We investigated 21 patients with PD and eight healthy controls. Ten of the patients were de novo at the time of the first

A tale of two factors: What determines t

A tale of two factors: What determines the rate of progression in Huntington's disease? A longitudinal MRI study

✍ H. Diana Rosas; Martin Reuter; Gheorghe Doros; Stephanie Y. Lee; Tyler Triggs; K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB

Over the past several years, increased attention has been devoted to understanding regionally selective brain changes that occur in Huntington's disease and their relationships to phenotypic variability. Clinical progression is also heterogeneous, and although CAG repeat length influences age of ons